Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Will Maintenance Sell In NSCLC? Experts Weigh Costs Against Benefits

Sep 13 2010

• By Emily Hayes

Related Content

ASCO Leaders Endorse Long-Term Use Of Revlimid And Rituxan To Prevent Relapse

May 20 2010

Regulatory Updates, In Brief

Apr 26 2010

U.K.'s Controversial NICE Suspends Publication Of Guidances Until After General Election

Apr 09 2010

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window